|IRB13-1469||Phase I, Open-Label, Safety, Tolerability, and Immunogenicity Study of VGX-3100 and INO-9012 Delivered by Electroporation (EP) in Women With Cervical Cancer After Chemoradiation
|IRB14-0081||Phase I, Multicenter, Cohort Dose Escalation Trial to Determine the Safety, Tolerance, and Maximum Tolerated Dose of DCR-MYC, a Lipid Nanoparticle (LNP)-Formulated Small Inhibitory RNA (siRNA) Oligonucleotide Targeting MYC, in Patients with Refractory Locally Advanced or Metastatic Solid Tumor Malignancies, Multiple Myeloma, or Lymphoma
|16682B||Long Term Database Collection for Cervical Cancer
|12-1039||GOG 274: A Phase III Trial of Adjuvant Chemotherapy as Primary Treatment for
Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The Outback Trial
(ANZGOG 0902/GOG-0274/RTOG 1174)
To learn more about cancer clinical trials or to make an appointment, call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials). Although our objective is to provide an updated listing of clinical trials, please note that a listing here does not guarantee that a trial is open or available to any specific patient. Additional trials may be available that are not listed. Complete information is available only from a treating physician.